Eli Lilly has announced promising results from a Phase 3 trial of its oral drug, orforglipron. The trial demonstrated significant efficacy in reducing weight and blood sugar levels in patients with type 2 diabetes. Significant Weight Loss and Blood Sugar Control with Orforglipron In the 40-week study, patients taking orforglipron lost up to 7.9% of their body weight (approximately 16…
Tag: diabetes
-
Competition Commission probes insulin price fixing
The Competition Commission in South Africa has launched a formal investigation into leading insulin manufacturers Novo Nordisk and Sanofi Aventis following serious allegations of anti-competitive conduct. The inquiry was initiated after health activists complained about Novo Nordisk’s decision to cease supplying human insulin pens to the country’s Health Department in 2024. This move has forced thousands of diabetic patients to…